The state of the hunt:
Pfizer/BioNTech asked the U.S. FDA to expand its authorization of their vaccine to adolescents.Numerous countries restricted the use of the AstraZeneca/Oxford shot to older people—or discontinued it altogether—even as regulators concluded the benefits outweighed the risks.
COVAX affirmed that SII’s supply commitments to the initiative remain “legally binding” amid continued export restrictions from India.
Vaccines
…